Neuroendocrine modulation of cancer progression

Brain, Behavior, and Immunity

Volumn 23, Issue 1, 2009, Pages 10-15

  Armaiz Pena, Guillermo N ^a   Lutgendorf, Susan K ^b   Cole, Steve W ^c   Sood, Anil K ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Behavioral stress; Cancer; Metastasis

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CORTICOTROPIN; DOPAMINE; HYDROCORTISONE; INTERLEUKIN 6; NEUROPEPTIDE; NORADRENALIN; OXYTOCIN; PROLACTIN; STAT3 PROTEIN; SUBSTANCE P; VASCULOTROPIN;

ANGIOGENESIS; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; DRUG MECHANISM; EXTRACELLULAR MATRIX; HUMAN; MENTAL STRESS; METASTASIS; NEUROENDOCRINE SYSTEM; NEUROMODULATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; DEPRESSION; DISEASE PROGRESSION; HUMANS; NEOPLASMS; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS; PSYCHONEUROIMMUNOLOGY; STRESS, PSYCHOLOGICAL;

EID: 56949093848     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2008.06.007     Document Type: Review

References (43)

1. Antoni M.H., Lutgendorf S.K., Cole S.W., Dhabhar F.S., Sephton S.E., McDonald P.G., Stefanek M., and Sood A.K. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 6 (2006) 240-248
2. Basu S., Nagy J.A., Pal S., Vasile E., Eckelhoefer I.A., Bliss V.S., Manseau E.J., Dasgupta P.S., Dvorak H.F., and Mukhopadhyay D. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat. Med. 7 (2001) 569-574
3. Bissell M.J. Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland. Biochem. Soc. Trans. 35 (2007) 18-22
4. Bleiker E.M., Hendriks J.H., Otten J.D., Verbeek A.L., and van der Ploeg H.M. Personality factors and breast cancer risk: a 13-year follow-up. J. Natl. Cancer Inst. 100 (2008) 213-218
5. Bos J.L. Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 31 (2006) 680-686
6. Carie A.E., and Sebti S.M. A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Oncogene 26 (2007) 3777-3788
7. Cassoni P., Marrocco T., Deaglio S., Sapino A., and Bussolati G. Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors. Ann. Oncol. 12 Suppl. 2 (2001) S37-S39
8. Chan A.S., Ng L.W., Poon L.S., Chan W.W., and Wong Y.H. Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress. Apoptosis 12 (2007) 167-179
9. Cohen R.J., Glezerson G., and Haffejee Z. Neuro-endocrine cells-a new prognostic parameter in prostate cancer. Br. J. Urol. 68 (1991) 258-262
10. Costanzo E.S., Lutgendorf S.K., Sood A.K., Anderson B., Sorosky J., and Lubaroff D.M. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 104 (2005) 305-313
11. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
12. Cox M.E., Deeble P.D., Lakhani S., and Parsons S.J. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res. 59 (1999) 3821-3830
13. Drell T.L., Joseph J., Lang K., Niggemann B., Zaenker K.S., and Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res. Treat. 80 (2003) 63-70
14. Duijts S.F., Zeegers M.P., and Borne B.V. The association between stressful life events and breast cancer risk: a meta-analysis. Int. J. Cancer 107 (2003) 1023-1029
15. Esteban F., Munoz M., Gonzalez-Moles M.A., and Rosso M. A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev. 25 (2006) 137-145
16. Flaxman B.A., and Harper R.A. In vitro analysis of the control of keratinocyte proliferation in human epidermis by physiologic and pharmacologic agents. J. Invest. Dermatol. 65 (1975) 52-59
17. Glaser R., and Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5 (2005) 243-251
18. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
19. Jean D., and Bar-Eli M. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol. Cell. Biochem. 212 (2000) 19-28
20. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., Atkinson C., Malarkey W.B., and Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 100 (2003) 9090-9095
21. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Carlson E.J., Hargreaves R.J., and Rupniak N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281 (1998) 1640-1645
22. Landen Jr. C.N., Lin Y.G., Armaiz Pena G.N., Das P.D., Arevalo J.M., Kamat A.A., Han L.Y., Jennings N.B., Spannuth W.A., Thaker P.H., Lutgendorf S.K., Savary C.A., Sanguino A.M., Lopez-Berestein G., Cole S.W., and Sood A.K. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res. 67 (2007) 10389-10396
23. Langley R.R., and Fidler I.J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr. Rev. 28 (2007) 297-321
24. Lillberg K., Verkasalo P.K., Kaprio J., Teppo L., Helenius H., and Koskenvuo M. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am. J. Epidemiol. 157 (2003) 415-423
25. Lutgendorf S.K., Cole S., Costanzo E., Bradley S., Coffin J., Jabbari S., Rainwater K., Ritchie J.M., Yang M., and Sood A.K. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 9 (2003) 4514-4521
26. Lutgendorf S.K., Johnsen E.L., Cooper B., Anderson B., Sorosky J.I., Buller R.E., and Sood A.K. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 95 (2002) 808-815
27. Mercurio A.M., and Rabinovitz I. Towards a mechanistic understanding of tumor invasion-lessons from the alpha6beta 4 integrin. Semin. Cancer Biol. 11 (2001) 129-141
28. Nakane T., Szentendrei T., Stern L., Virmani M., Seely J., and Kunos G. Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells. J. Immunol. 145 (1990) 260-266
29. Nilsson M.B., Armaiz-Pena G., Takahashi R., Lin Y.G., Trevino J., Li Y., Jennings N., Arevalo J., Lutgendorf S.K., Gallick G.E., Sanguino A.M., Lopez-Berestein G., Cole S.W., and Sood A.K. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J. Biol. Chem. 282 (2007) 29919-29926
30. Nilsson M.B., Langley R.R., and Fidler I.J. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res. 65 (2005) 10794-10800
31. Perron L., Bairati I., Harel F., and Meyer F. Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control 15 (2004) 535-541
32. Pifl C., Zezula J., Spittler A., Kattinger A., Reither H., Caron M.G., and Hornykiewicz O. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter. FASEB J. 15 (2001) 1607-1609
33. Price M.A., Tennant C.C., Smith R.C., Butow P.N., Kennedy S.J., Kossoff M.B., and Dunn S.M. The role of psychosocial factors in the development of breast carcinoma: Part I. The cancer prone personality. Cancer 91 (2001) 679-685
34. Reiche E.M., Nunes S.O., and Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 5 (2004) 617-625
35. Richert, M.M., Decker, K., Anderson, S.M., 2001. Mechanisms underlying constitutive action of Akt in breast cancer cell lines. In: Proceedings of the 83rd Annual Meeting of the Endocrine Society, p. 551.
36. Sastry K.S., Karpova Y., Prokopovich S., Smith A.J., Essau B., Gersappe A., Carson J.P., Weber M.J., Register T.C., Chen Y.Q., Penn R.B., and Kulik G. Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J. Biol. Chem. 282 (2007) 14094-14100
37. Saul A.N., Oberyszyn T.M., Daugherty C., Kusewitt D., Jones S., Jewell S., Malarkey W.B., Lehman A., Lemeshow S., and Dhabhar F.S. Chronic stress and susceptibility to skin cancer. J. Natl. Cancer Inst. 97 (2005) 1760-1767
38. Shin V.Y., Wu W.K., Chu K.M., Koo M.W., Wong H.P., Lam E.K., Tai E.K., and Cho C.H. Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol. Sci. 96 (2007) 21-29
39. Sood A.K., Bhatty R., Kamat A.A., Landen C.N., Han L., Thaker P.H., Li Y., Gershenson D.M., Lutgendorf S., and Cole S.W. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res. 12 (2006) 369-375
40. Thaker P.H., Han L.Y., Kamat A.A., Arevalo J.M., Takahashi R., Lu C., Jennings N.B., Armaiz-Pena G., Bankson J.A., Ravoori M., Merritt W.M., Lin Y.G., Mangala L.S., Kim T.J., Coleman R.L., Landen C.N., Li Y., Felix E., Sanguino A.M., Newman R.A., Lloyd M., Gershenson D.M., Kundra V., Lopez-Berestein G., Lutgendorf S.K., Cole S.W., and Sood A.K. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12 (2006) 939-944
41. Thaker P.H., and Sood A.K. Neuroendocrine influences on cancer biology. Semin. Cancer Biol. 18 (2007) 164-170
42. Yang E.V., Donovan E.L., Benson D.M., and Glaser R. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav. Immun. 22 (2008) 318-323
43. Yang E.V., Sood A.K., Chen M., Li Y., Eubank T.D., Marsh C.B., Jewell S., Flavahan N.A., Morrison C., Yeh P.E., Lemeshow S., and Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 66 (2006) 10357-10364